首页> 美国卫生研究院文献>Netherlands Heart Journal >Cardiac surgery and percutaneous intervention in pregnant women with heart disease
【2h】

Cardiac surgery and percutaneous intervention in pregnant women with heart disease

机译:心脏病孕妇的心脏手术和经皮介入治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In pregnant women with heart disease, complications can arise due to the haemodynamic burden of pregnancy and to hypercoagulation. Most problems can be managed medically, but sometimes cardiac surgery or percutaneous intervention is unavoidable. Cardiac surgery has similar maternal mortality to that outside pregnancy, but foetal mortality and morbidity are considerable. Measures to reduce the risk by adaptation of the management of cardiopulmonary bypass are described. When gestational age is > 28 weeks, pre-surgery delivery of the foetus should be considered. Percutaneous intervention exposes the foetus to radiation. The radiation dose for common cardiac procedures, however, does not result in detectable harmful foetal effects.
机译:在患有心脏病的孕妇中,由于怀孕的血液动力学负担和血凝过多,会引起并发症。大多数问题可以通过医学手段解决,但是有时心脏手术或经皮干预是不可避免的。心脏手术的孕产妇死亡率与妊娠外的死亡率相似,但是胎儿的死亡率和发病率相当高。描述了通过适应体外循环管理降低风险的措施。当胎龄大于28周时,应考虑手术前胎儿的分娩。经皮干预使胎儿受到辐射。但是,普通心脏手术的辐射剂量不会导致可检测到的有害胎儿影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号